Chugai Presents Results from Phase III Study of Satralizumab in NMOSD at ECTRIMS 2018
2018-10-15
Dear Investor,
Please find attached a press release by Chugai.
Do not hesitate to contact us for any further questions.
Investors
Investor updates
stay updated
get the latest news and updates to your inbox.